FilingsTodayBristol Myers Squibb
At a glance
Bristol Myers Squibb reported 2025 revenue of $48.19B, down 0.2% from $48.3B in 2024. Over 4 years since 2021 ($46.38B), that is growth of about 1% a year. Revenue peaked in 2024 at $48.3B. The company posted a loss in 2024.
In the last 12 months 3 insiders reported 0 open-market purchases and 3 sales ($2.3M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $1.9M by EVP, Chief Financial Officer David V Elkins on Apr 2, 2026.
Bristol Myers Squibb filed 9 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), other events (3), shareholder vote results (1) and regulation fd disclosure (1).
1 of the 20 investors tracked here held Bristol Myers Squibb at the last quarter end, worth $321.4M combined. It is the largest weight for National Pension Service (Korea) (0.2% of its portfolio).
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $6.99B | $6.33B | $8.03B | -$8.95B | $7.05B |
| Diluted EPS | $3.12 | $2.95 | $3.86 | $-4.41 | $3.46 |
| Dividend per share | $2.01 | $2.19 | $2.31 | $2.42 | $2.49 |
Fiscal year ends Dec 31 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined